References
- Acosta EP, Flexner C. (2011). Antiviral agents (nonretroviral). Chapter 58. In: Brunton LL, Chabner BA, Knollmann BC, eds. Goodman & Gilman's the pharmacological basis of therapeutics. 12th ed. Available from: http://accessmedicine.mhmedical.com/content.aspx?bookid=374&Sectionid=41266269 [last accessed 3 Mar 2014]
- Bennett JE. (2011). Antifungal agents. Chapter 57. In: Brunton LL, Chabner BA, Knollmann BC, eds. Goodman & Gilman's the pharmacological basis of therapeutics. 12th ed. Available from: http://accessmedicine.mhmedical.com/content.aspx?bookid=374&Sectionid=41266268 [last accessed 3 Mar 2014]
- British Pharmacopoeia. (2013). Available from: http://www.pharmacopoeia.co.uk [last accessed 9 Sep 2013]
- Dawson B, Trapp RG. (2004). Basic & clinical biostatistics. 4th ed. New York: McGraw-Hill, 438
- Dias M, Farinha A, Faustino E, et al. (1999). Topical delivery of caffeine from some commercial formulations. Int J Pharm 182:41–7
- Du Plessis LH, Lubbe J, Strauss T, Kotzé AF. (2010). Enhancement of nasal and intestinal calcitonin delivery by the novel Pheroid™ fatty acid based delivery system, and by N-trimethyl chitosan chloride. Int J Pharm 358:181–6
- Durden FM, Elewski B. (1997). Fungal infections in HIV-infected patients. Semin Cutaneous Med Surg 16:200–12
- Flynn GL. (2002). Cutaneous and transdermal delivery – processes and systems of delivert. In: Banker GS, Rhodes CT, eds. Modern pharmaceutics. 4th ed. New York: Marcel Dekker, 187–235
- Gerber M, Breytenbach JC, Du Plessis J. (2008). Transdermal penetration of zalcitabine, lamivudine and synthesized N-acyl lamivudine esters. Int J Pharm 351:186–93
- Grobler A, Kotze A, Du Plessis J. (2008). The design of a skin-friendly carrier for cosmetic compounds using Pheroid™ technology. In: Wiechers J, ed. Science and applications of skin delivery systems. Wheaton, IL: Allured, 283–311
- International Conference on Harmonisation of Technical requirements for registration of pharmaceuticals for human use (ICH): QlA (R2). (2003). Stability testing of new drug substances and products. Available from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q1A_R2/Step4/Q1A_R2__Guideline.pdf [last accessed 5 March 2014]
- Jiang M, Qureshi SA, Midah KK, Skelly JP. (1998). In vitro evaluation of percutaneous absorption of an acyclovir product using intact and tape-stripped human skin. J Pharm Pharmaceut Sci 1:102–7
- Leveque N, Makki S, Hadgraft J, Humbert PH. (2004). Comparison of Franz cells and microdialysis for assessing salicylic acid penetration through human skin. Int. J Pharm 269:323–8
- McEvoy GK. (2002). AHFS drug information. Bethesda: American Society of Health System Pharmacist, 3765
- Medicines control council (MCC). (2010). Stability: registration of medicine. Republic of South Africa. Available from: http://www.sacra.za.net/site/files/5909/2.05%20Stability%20Jun10%20v5%20final.pdf [last accessed 3 Mar 2014]
- Menon GK. (2002). New insights into skin structure: scratching the surface. Adv Drug Deliver Rev 54:3–17
- Pellet MA, Hadgraft J, Roberts MS. (1999). The back diffusion of glucose across human skin in vitro. Int J Pharm 193:27–35
- Pellet MA, Roberts MS, Hadgraft J. (1997). Supersaturated solutions evaluated with an in vitro stratum corneum tape stripping technique. Int J Pharm 151:91–8
- Pershing LK, Corlett J, Jorgensen C. (1994). In vitro pharmacokinetics and pharmacodinamics of topical ketoconazole and miconazole in human stratum corneum. Antimicrob Agents Chemother 38:90–5
- Ramdial PK. (2000). Selected topics in HIV-associated skin pathology. Curr Pathol Diagn 6:113–24
- SAS Institute. (2013). SAS online doc, version 9.3. Available from: http://www.sas.com [last accessed 1 Nov 2013]
- Saunders JCJ, Davis HJ, Coetzee L, et al. (1999). A novel skin penetration enhancers: evaluation by membrane diffusion and confocal microscopy. J Pharm Pharmaceut Sci 2:99–107
- Skiba M, Marchais H, Duclos R, Arnaud P. (2000). Stability assessment of ketoconazole in aqueous formulations. Int J Pharm 198:1–6
- Statsoft. (2013). Statistica, version 11. Available from: http://www.statsoft.co.za [last accessed 1 Nov 2013]
- Steyn AGW, Smit CF, Du Toit SHC, Strasheim C. (1994). Modern statistics in practice. Pretoria: Van Schaik, 640
- Steyn JD, Wiesner L, Du Plessis LH, et al. (2011). Absorption of the novel artemisinin derivatives artemisone and artemiside: potential application of Pheroid™ technology. Int J Pharm 414:260–6
- Thomas BJ, Finnin BC. (2004). The transdermal revolution. Drug Discov Today 9:697–703
- Yen-More A, Straten MV, Carrasco D, et al. (2000). Cutaneous viral infections in HIV-infected individuals. Clin Dermatol 18:423–32